RadNet (RDNT) 47th Annual Raymond James Institutional Investor Conference summary

Financial outlook and growth drivers

• Imaging center revenue projected to grow 16–18% in 2026, with digital health expected to increase by around 50% year-over-year.

• EBITDA growth in imaging centers is anticipated to outpace revenue, indicating margin expansion.

• Advanced imaging modalities (MRI, CT, PET CT) are experiencing mid- to high-single-digit same-store growth, with PET CT in double digits.

• Recent acquisitions, including a major one in Southwest Florida, are expected to contribute mid- to high-single-digit EBITDA growth.

• Medicare reimbursement and commercial payer benefits, as well as new center openings and joint ventures, are factored into guidance.

Operational headwinds and efficiency initiatives

• Labor costs are projected to rise by about 4% same-center, equating to roughly $30 million.

• Severe winter weather in the Northeast and Mid-Atlantic is expected to impact Q1 by $7–9 million, less than last year's $15 million weather-related EBITDA hit.

• Stock-based compensation has increased due to digital health expansion but is expected to flatten going forward.

• Automation and AI-driven call center solutions are being implemented to reduce $60 million in annual human call center costs, targeting at least 10% savings.

Technology and digital health strategy

• Digital health is structured around workflow solutions (RIS, PACS) and clinical AI, unified under DeepHealth OS.

• Recent M&A has expanded clinical AI capabilities across MRI, CT, ultrasound, mammography, and X-ray.

• The vision is for all images to be processed by AI, improving radiologist productivity and report turnaround.

• Gleamer acquisition brings AI-assisted X-ray reads and autonomous reporting, aiming to reduce burnout and improve efficiency.

• Four FDA approvals are expected in the next quarters for lung, prostate, breast, and ultrasound AI products.